Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 12, 2003

View Archived Issues

Use of rhBMP-2 in lumbar arthrodesis

Four series of tyrosine kinase inhibitors identified at Ariad

Novel antibacterial DNA polymerase III inhibitors prepared and tested at Bayer

New antibacterial agents with PPAT-inhibitory activity discovered at Bayer

Bayer identifies novel thyroid hormone-like agents with utility in arteriosclerosis

Pfizer claims MTP/apo B secretion inhibitors for use in obesity and related disorders

Elan and Pharmacia team identifies novel beta-secretase inhibitors

OSI to acquire Cell Pathways

MedImmune responds to FluMist complete response letter

Pharmacopeia and AstraZeneca extend research collaboration

Milestone achieved in Pharmacopeia and Berlex collaboration

Johnson & Johnson to acquire Scios

Milnacipran improves pain in phase II FMS study

BioMarin presents overview of recent highlights

Transgene announces encouraging results from phase I oncology trials

Preclinical profile of HIV-specific CCR5 inhibitor presented in Boston

Favorable anti-HIV interactions for combination of CCR5 inhibitor and other antiretrovirals

Excellent activity reported for TMC-114 against protease inhibitor-resistant HIV

Anti-HIV effects of Racivir + d4T + efavirenz sustained after cessation of treatment in humans

AstraZeneca completes MRP in E.U. for Symbicort Turbuhaler in COPD

FDA approves Zoloft for social anxiety disorder

AstraZeneca submits MAA for Iressa for advanced NSCLC

SuperGen submits second module of rolling NDA for Orathecin

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Hippocratic loath? ‘Harm’ threat from ACIP’s proposed HBV shift
BioWorld
Individual liberty and choice vs. wider public health became one predictable hinge upon which swung the often-acerbic debates at the CDC’s Advisory Committee for...
Høeg appointment as acting CDER director tied to vaccine strategy?
BioWorld
After a more than 13-year period of stability with Janet Woodcock as the head of CDER, with Patrizia Cavazzoni taking charge during the next four years of former...
First phase of synthetic human genome project successfully completes
BioWorld
The first phase of the U.K. synthetic human genome project has successfully completed, realizing key steps in chromosome synthesis. The work has demonstrated a...